Nanomolar to sub-picomolar affinity measurements of antibody-antigen interactions and protein multimerizations: fluorescence-assisted high-performance liquid chromatography.

[1]  Theo Rispens,et al.  Adalimumab elicits a restricted anti-idiotypic antibody response in autoimmune patients resulting in functional neutralization , 2012 .

[2]  D. Myszka,et al.  Femtomolar Fab binding affinities to a protein target by alternative CDR residue co-optimization strategies without phage or cell surface display , 2012, mAbs.

[3]  J. Melero,et al.  Characterization of neutralizing affinity‐matured human respiratory syncytial virus F binding antibodies in the sub‐picomolar affinity range , 2012, Journal of molecular recognition : JMR.

[4]  T. Rispens,et al.  Mechanism of immunoglobulin G4 Fab-arm exchange. , 2011, Journal of the American Chemical Society.

[5]  P. Hemker,et al.  Label-free assessment of high-affinity antibody-antigen binding constants. Comparison of bioassay, SPR, and PEIA-ellipsometry. , 2011, Journal of immunological methods.

[6]  Bill Pikounis,et al.  Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor α , 2010, mAbs.

[7]  E. Sasso,et al.  Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor. , 2009, Clinical immunology.

[8]  Andreas Plückthun,et al.  Directed evolution of an anti-prion protein scFv fragment to an affinity of 1 pM and its structural interpretation. , 2006, Journal of molecular biology.

[9]  Timothy Londergan,et al.  Looking towards label-free biomolecular interaction analysis in a high-throughput format: a review of new surface plasmon resonance technologies. , 2006, Current opinion in biotechnology.

[10]  Qinjian Zhao,et al.  Determination of picomolar equilibrium dissociation constants in solution by enzyme-linked immunosorbent assay with fluorescence detection. , 2005, Analytical biochemistry.

[11]  L. Roskos,et al.  Demonstration of an in vivo generated sub-picomolar affinity fully human monoclonal antibody to interleukin-8. , 2005, Biochemical and biophysical research communications.

[12]  David G Myszka,et al.  Characterizing high-affinity antigen/antibody complexes by kinetic- and equilibrium-based methods. , 2004, Analytical biochemistry.

[13]  J. Foote,et al.  Breaking the affinity ceiling for antibodies and T cell receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D. Winzor,et al.  From gel filtration to biosensor technology: the development of chromatography for the characterization of protein interactions , 2000, Journal of molecular recognition : JMR.

[15]  G Gauglitz,et al.  Assessment of affinity constants by rapid solid phase detection of equilibrium binding in a flow system. , 1997, Journal of immunological methods.

[16]  R. E. Huber,et al.  Monomer-dimer equilibrium of uncomplemented M15 beta-galactosidase from Escherichia coli. , 1997, Biochemistry.

[17]  J. Foote,et al.  Kinetic and affinity limits on antibodies produced during immune responses. , 1995, Proceedings of the National Academy of Sciences of the United States of America.